021-51111890
购物车（）
sales@molnova.cn
Gadoxetate Disodium
CAS No. 135326-22-6
Gadoxetate Disodium ( Gd-EOB-DTPA Disodium,ZK 139834 )
产品货号. M22181 CAS No. 135326-22-6
Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥300 | 有现货 |
|
| 5MG | ￥478 | 有现货 |
|
| 10MG | ￥786 | 有现货 |
|
| 25MG | ￥1450 | 有现货 |
|
| 50MG | ￥2576 | 有现货 |
|
| 100MG | ￥3831 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Gadoxetate Disodium
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging.
-
产品描述Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, functioning hepatocytes.
-
同义词Gd-EOB-DTPA Disodium,ZK 139834
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Others
-
适应症Transient Severe Arterial Phase Motion
化学信息
-
CAS Number135326-22-6
-
分子量725.71
-
分子式C23H28GdN3Na2O11
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[Na+].[Na+].[Gd+3].CCOc1ccc(CC(CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Schuhmann-Giampieri G, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992 Apr;183(1):59-64.
产品手册
关联产品
-
Gancaonin N
Gancaonin N is a natural product for research related to life sciences.
-
VK-II-36
VK-II-36, a carvedilol analog, suppresses sarcoplasmic reticulum (SR) Ca(2+) release but does not block the β-receptor.
-
5α-Pregnane-3β,6α-di...
5α-Pregnane-3β,6α-diol-20-one is a mitogenic metabolite of progesterone. It can be produced in starved androgen-responsive prostate cancer cells.
